2019

28 Jun 2019
Golden Meditech Announces FY2018/2019 Annual Results
Hong Kong, 28 June 2019 – Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces today its annual results for the year ended 31 March 2019 (the "Year").
24 May 2019
Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons, New Members on Board, the Company's Major Shareholder Maintains Full Confidence in Future Business Development
Hong Kong, 24 May 2019 - Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announced that, Mr Kam Yuen ("Mr Kam") and Mr Kong Kam Yu ("Mr Kong"), executive directors of the Company, Ms Zheng Ting ("Ms Zheng"), non-executive director, Professor Gu Qiao and Professor Cao Gang, independent non-executive directors, voluntarily resigned due to personal reasons.
17 Apr 2019
Golden Meditech and HKBU Team up to Conduct Cell Therapy Research
Hong Kong, 17 April 2019 - Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise in China, announced that it has formed a collaboration with the Department of Biology of Hong Kong Baptist University ("HKBU") to conduct in-depth research in the area of cell therapy, particularly treating neurodegenerative diseases with stem cells.

Please download the latest "Acrobat Reader" to view the PDF.

Back to top